I think it soeaks volumes that the Company hasnt PR'd about the Ph2 longhauler study yet (have they?).

But it probably has more ro do with the fact that they already have more than enough interest to fill the trial; why waste money on a fluffy PR especiallt if it might take away from the real big news soon.